America Handing MRNA Lead: Investors Reassess Biotech
A political shift in the United States is denting confidence in mRNA medicine, with funding drying up and manufacturi...
This piece explains why index fund performance changes over time and what factors investors should monitor for better outcomes.
27,966 articlesA political shift in the United States is denting confidence in mRNA medicine, with funding drying up and manufacturi...
U.S. companies are winning on AI adoption, pushing workers to use AI at scale while facing runaway costs and costly m...
XRP trades in a narrow range as three big headwinds keep gains at bay. Analysts flag Bitcoin correlation, whale selli...
A betting meme links celebrity attendance to home-team losses, prompting bettors to rethink risk in personal finance ...
Fluence Energy’s stock surged after-hours on news of two hyperscaler storage deals, even as Q2 revenue disappointed. ...
June 2026 opens with a handful of beaten-down stocks that could roar back as inflation cools and earnings beat expect...
Morgan Stanley labels Microsoft the most under-owned megacap as the stock slides this year. A $50 billion AI investme...
DraftKings reports a mixed Q1 2026 while signaling growth hinges on prediction markets and regulatory clarity. A path...
Trump unveils an expanded financial footprint in a new annual disclosure, highlighting Apple stock, commemorative coi...
OpenAI is nearing a private funding round that could push its valuation above $850 billion, a level that would outstr...
Solana is trading near $97 as traders weigh a potential move above $100 this month. Analysts point to ETF demand and ...
Micron unveils a $200 billion expansion to meet AI memory demand, and the company says even customers couldn’t foreca...